
The Dog Aging Project details 50,188 companion dogs, longitudinal health data and the limits of observational research on healthy aging.

On 2026-11-04, a GeroScience study-design paper described the Dog Aging Project's long-term companion-dog cohort. Texas A&M separately reported a new funded phase to continue following dogs and expand research on genetics, nutrition and home environments.
The report's central contribution is a large research resource for tracking how dogs' health and survival change over time. The paper reports 50,188 enrolled dogs across all 50 states and the District of Columbia as of December 31, 2024. It also records 14,978 documented deaths at that cutoff. Together, the longitudinal health information and mortality records provide a foundation for studying aging trajectories and identifying factors associated with healthy lifespan.
Study model: Observational animal research in companion dogs living in ordinary home environments.
According to the design paper, the Dog Aging Project began in 2019 to investigate biological and environmental factors associated with healthy aging. Its DAP Pack is a prospective, longitudinal and open cohort. Researchers collect information over time rather than relying entirely on a snapshot of dogs at a single point in their lives.
The home setting is central to the authors' rationale. Owners supply information about their dogs' health histories and daily circumstances. The surveys cover diet and medications as well as preventive treatments. They also record physical activity, behavior and features of home and outdoor environments.
Owners are asked to complete annual follow-up surveys covering changes in health and circumstances. These updates include activity, medication and diagnoses alongside environmental and behavioral information. At the reported cutoff, more than half of the enrolled dogs had follow-up data spanning up to five years. This repeated collection gives researchers a way to examine how recorded circumstances and health outcomes unfold together.
The project supplements those reports with geographically linked information. According to the paper, this includes census indicators and air-pollution estimates as well as weather and climate measures. These additions give researchers environmental context beyond an owner's description of a home. They also create opportunities to ask questions that connect health records with the places where dogs live.
The primary endpoint is all-cause mortality, meaning death from any cause. Secondary endpoints include chronic disease diagnoses, cognitive decline and physical function. Those outcomes keep survival and functioning visible as distinct research questions. When reading about canine aging measurements, it helps to ask which health outcomes a study actually follows.
The resource is also designed for use beyond the project's immediate research team. Researchers can access annual curated releases at no charge after signing a Data Use Agreement. The paper says public access follows a one-year lag. Its authors also report that project researchers and collaborators had published more than 50 papers using DAP data as of the report.
A companion GeroScience mortality analysis illustrates one use of the resource. It examined 41,047 dogs and reported median lifespan ranging from 14 years in small dogs to less than 10 years in giant American Kennel Club-recognized breeds. That paper addresses findings within a defined analysis. The design paper instead explains the broader platform from which such analyses are drawn.
Continued data collection is part of the next funded phase. Texas A&M reported a five-year National Institute on Aging plan with approximately $29 million in NIH support, beginning with a $6.1 million first-year award. The stated priorities include continued follow-up and expanded research on genetics, nutrition and home environments. For readers evaluating the project, these are commitments to further research rather than reported health benefits.
The design paper makes its weaknesses explicit. They affect different questions in different ways, so the useful approach is to connect each limitation to the conclusion being considered.
The next step is to test whether the most consistent associations hold up in further longitudinal analyses and then use those results to prioritize targeted mechanistic studies or controlled trials.
The size of a dog cohort can distract from the fact that its findings concern dogs. AgeAmaze helps readers keep that distinction visible through clear explanations of longevity biology and evidence strength, addressing confusion between animal studies and human research without recasting preliminary observations as health promises.
Stay current with research on aging biology, biomarkers, nutrition, therapeutics, peptides and longevity technology. AgeAmaze reports what the evidence shows, where uncertainty remains and which claims still need stronger data.



Follow AgeAmaze for careful reporting on what longevity science can show today and what still needs stronger evidence.
read the Blog